Related Experiment Videos
Borderline functioning, work, and outcome in intensive evening group treatment.
A S Joyce1, M McCallum, W E Piper
1Department of Psychiatry, University of Alberta.
International Journal of Group Psychotherapy
|July 3, 1999
Summary
This study identified distinct patient subgroups within borderline personality disorder (BPD) receiving intensive evening treatment. Findings reveal how BPD traits impact treatment engagement and outcomes in group therapy.
Area of Science:
- Psychiatry
- Clinical Psychology
- Behavioral Science
Background:
- Borderline Personality Disorder (BPD) presents complex challenges for treatment.
- Intensive, group-oriented programs aim to address BPD symptoms.
- Understanding patient heterogeneity is crucial for optimizing therapeutic interventions.
Purpose of the Study:
- To identify distinct subgroups of patients with BPD based on pretherapy characteristics.
- To explore how these subgroups differ in their engagement and response to an intensive evening treatment program.
- To investigate the relationship between patient attributes, therapeutic work, and treatment outcomes in BPD.
Main Methods:
- Cluster analysis was employed on pretherapy outcome measures for 40 BPD patients.
- Discriminant-function analysis was used to differentiate identified clusters.
- Relationships between patient dimensions, therapeutic work, and treatment outcomes were examined.
Main Results:
- Eight initial patient clusters were identified; two were excluded due to single-patient definition.
- Four key dimensions emerged, differentiating the remaining six BPD patient clusters.
- Significant associations were found between these dimensions, therapeutic engagement, and treatment outcomes.
Conclusions:
- Behavioral characteristics inherent to BPD significantly influence participation and benefits derived from intensive group treatment.
- The identified patient subgroups offer a basis for tailoring treatment strategies for BPD.
- These findings have implications for enhancing the understanding and clinical management of BPD.